Julie A Fields Selected Research

aspartyl- arginyl- valyl- tyrosyl- isoleucyl- histidyl- prolyl- phenylalanyl- histidyl- leucyl- valyl- isoleucyl- histidine (hTDP)

5/2020

TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie A Fields Research Topics

Disease

15	Dementia (Dementias) 01/2022 - 01/2003
12	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2006
10	Cognitive Dysfunction 11/2021 - 06/2003
7	Parkinson Disease (Parkinson's Disease) 01/2016 - 06/2002
6	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 01/2018
3	Atrophy 01/2022 - 01/2021
3	Parkinsonian Disorders (Parkinsonism) 01/2021 - 03/2012
3	Frontotemporal Dementia (Semantic Dementia) 10/2019 - 03/2012
2	Disease Progression 01/2022 - 01/2021
2	Mania (Manias) 09/2014 - 01/2012
2	Essential Tremor (Essential Tremors) 09/2005 - 06/2003
1	Neoplasms (Cancer) 11/2021
1	Prodromal Symptoms 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Pre-Eclampsia (Preeclampsia) 01/2020
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020
1	Amyloidosis 10/2019
1	Proteostasis Deficiencies 10/2019
1	Tauopathies 10/2019
1	Psychotic Disorders (Schizoaffective Disorder) 09/2014
1	Ataxia (Dyssynergia) 07/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2012
1	Frontotemporal Dementia With Motor Neuron Disease 03/2012

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
7	Amyloid (Amyloid Fibrils)IBA 11/2021 - 01/2017
3	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 01/2017
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2021 - 01/2017
3	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021 - 01/2018
2	SynucleinsIBA 11/2021 - 01/2020
2	Apolipoproteins E (ApoE)IBA 12/2020 - 10/2006
2	N 30IBA 01/2020 - 03/2012
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022
1	IGF-I-IGFBP-3 complex FDA Link 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021
1	IronIBA 01/2021
1	aspartyl- arginyl- valyl- tyrosyl- isoleucyl- histidyl- prolyl- phenylalanyl- histidyl- leucyl- valyl- isoleucyl- histidine (hTDP)IBA 05/2020
1	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2020
1	Carbon-11IBA 12/2019
1	Apolipoprotein E4IBA 12/2019
1	Hormones (Hormone)IBA 01/2016
1	Prion ProteinsIBA 07/2013
1	Protons (Proton)IBA 07/2013
1	Levodopa (L Dopa)FDA LinkGeneric 09/2012
1	ApolipoproteinsIBA 10/2006

Therapy/Procedure

6	Deep Brain Stimulation 01/2016 - 06/2002
4	Therapeutics 01/2020 - 09/2005
3	Cognitive Training 12/2017 - 12/2014
1	Ovariectomy (Oophorectomy) 11/2021
1	Electrodes (Electrode) 01/2012
1	Microelectrodes 01/2003
1	Pallidotomy 01/2003